| Mycophenolate mofetil therapy for refractory inflammatory bowel disease. | |
| | |
MedLine Citation:
|
PMID: 17924566 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Mycophenolate mofetil (MMF) is an immunomodulatory drug, and its use in inflammatory bowel disease has previously been reported. The aim of this study was to review the Leeds Colitis Clinic experience of the safety and efficacy of MMF in treating patients with refractory Crohn's disease (CD) and ulcerative colitis (UC). This is an extension of a previously published study from our center with a longer follow-up period and approximately twice the number of patients. METHODS: A retrospective analysis was performed of the records of all patients treated with MMF for inflammatory bowel disease over a 5-year period. RESULTS: Of 70 patients identified, 67 had previously been treated with azathioprine unsuccessfully. Seventeen of the 70 patients had been successfully maintained in remission with MMF for an average duration of 33 months. Treatment with MMF was discontinued for 53 patients, 17 because of side effects and 36 because they had not responded to the treatment. CONCLUSIONS: In our series, 17 patients (24.3%) had a sustained steroid-free remission with MMF therapy. Nineteen patients (27%) experienced side effects, of which 17 (24.3% of the total group) had to discontinue therapy. An additional 36 (51.4%) required an escalation in medical therapy or surgery because of failure of the MMF therapy. MMF may have a role in the treatment of refractory inflammatory bowel disease, especially in patients who have previously failed standard therapies such as azathioprine. |
| | |
Authors:
|
S Palaniappan; A C Ford; D Greer; S M Everett; D M Chalmers; A T R Axon; P J Hamlin |
Related Documents
:
|
23454446 - The prevalence of fluid associated with the iliotibial band in asymptomatic recreationa... 3544376 - Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recip... 11157146 - Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffu... 19933596 - Influence of race/ethnicity on response to lupus nephritis treatment: the alms study. 11558196 - Polymyalgia rheumatica and giant cell arteritis. avoiding management traps. 16550976 - Comparison of lornoxicam with tramadol in patient-controlled analgesia after gynecologi... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Inflammatory bowel diseases Volume: 13 ISSN: 1078-0998 ISO Abbreviation: Inflamm. Bowel Dis. Publication Date: 2007 Dec |
Date Detail:
|
Created Date: 2007-11-12 Completed Date: 2008-02-14 Revised Date: 2013-05-29 |
Medline Journal Info:
|
Nlm Unique ID: 9508162 Medline TA: Inflamm Bowel Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 1488-92 Citation Subset: IM |
Affiliation:
|
Department of Gastroenterology, Leeds General Infirmary, Lees, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Azathioprine / therapeutic use Colitis, Ulcerative / drug therapy* Crohn Disease / drug therapy* Female Follow-Up Studies Humans Immunosuppressive Agents / adverse effects*, therapeutic use* Male Middle Aged Mycophenolic Acid / adverse effects, analogs & derivatives*, therapeutic use Retrospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Immunosuppressive Agents; 24280-93-1/Mycophenolic Acid; 446-86-6/Azathioprine; 9242ECW6R0/mycophenolate mofetil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genome-wide expression profiling during protection from colitis by regulatory T cells.
Next Document: Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of m...